###begin article-title 0
###xml 71 97 71 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 71 97 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Branched-chain amino acid aminotransferase and methionine formation in Mycobacterium tuberculosis
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Tuberculosis remains a major world-wide health threat which demands the discovery and characterisation of new drug targets in order to develop future antimycobacterials. The regeneration of methionine consumed during polyamine biosynthesis is an important pathway present in many microorganisms. The final step of this pathway, the conversion of ketomethiobutyrate to methionine, can be performed by aspartate, tyrosine, or branched-chain amino acid aminotransferases depending on the particular species examined.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 68 95 68 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 285 302 285 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 329 342 329 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 345 354 345 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. cereus</italic>
###xml 1083 1099 1080 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1121 1132 1118 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 1287 1298 1283 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 1325 1340 1320 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 68 100 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 285 302 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 329 341 <span type="species:ncbi:1392">B. anthracis</span>
###xml 345 354 <span type="species:ncbi:1396">B. cereus</span>
###xml 1083 1098 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1121 1131 <span type="species:ncbi:1781">M. marinum</span>
###xml 1287 1297 <span type="species:ncbi:1781">M. marinum</span>
###xml 1325 1340 <span type="species:ncbi:1773">M. tuberculosis</span>
The gene encoding for branched-chain amino acid aminotransferase in Mycobacterium tuberculosis H37Rv has been cloned, expressed, and characterised. The enzyme was found to be a member of the aminotransferase IIIa subfamily, and closely related to the corresponding aminotransferase in Bacillus subtilis, but not to that found in B. anthracis or B. cereus. The amino donor preference for the formation of methionine from ketomethiobutyrate was for isoleucine, leucine, valine, glutamate, and phenylalanine. The enzyme catalysed branched-chain amino acid and ketomethiobutyrate transamination with a Km of 1.77 - 7.44 mM and a Vmax of 2.17 - 5.70 mumol/min/mg protein, and transamination of ketoglutarate with a Km of 5.79 - 6.95 mM and a Vmax of 11.82 - 14.35 mumol/min/mg protein. Aminooxy compounds were examined as potential enzyme inhibitors, with O-benzylhydroxylamine, O-t-butylhydroxylamine, carboxymethoxylamine, and O-allylhydroxylamine yielding mixed-type inhibition with Ki values of 8.20 - 21.61 muM. These same compounds were examined as antimycobacterial agents against M. tuberculosis and a lower biohazard M. marinum model system, and were found to completely prevent cell growth. O-Allylhydroxylamine was the most effective growth inhibitor with an MIC of 78 muM against M. marinum and one of 156 muM against M. tuberculosis.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 109 124 109 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 109 124 <span type="species:ncbi:1773">M. tuberculosis</span>
Methionine formation from ketomethiobutyrate is catalysed by a branched-chain amino acid aminotransferase in M. tuberculosis. This enzyme can be inhibited by selected aminooxy compounds, which also have effectiveness in preventing cell growth in culture. These compounds represent a starting point for the synthesis of branched-chain aminotransferase inhibitors with higher activity and lower toxicity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 118 124 <span type="species:ncbi:9606">people</span>
Tuberculosis remains one of the leading causes of worldwide mortality and morbidity, infecting an estimated 8 million people annually with approximately 2 million deaths [1]. The situation regarding the control of tuberculosis has significantly worsened over the last decades, with the spread of multidrug resistant strains. In the absence of an effective vaccine for tuberculosis, there is an urgent need for the development of novel antimycobacterial agents. The study of mycobacterial biochemistry assists this development through the identification and characterization of cellular enzymes amenable to therapeutic inhibition.
###end p 9
###begin p 10
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 756 778 756 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 817 835 817 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 984 1001 984 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium spp</italic>
###xml 1093 1095 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 756 777 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 817 834 <span type="species:ncbi:1423">Bacillus subtilis</span>
Polyamine synthesis and its associated methionine (Met) regeneration pathway (Figure 1) are known to be potential drug targets in a variety of microorganisms [2-4]. The synthesis of polyamines is essential during periods of DNA replication, although the exact physiological role of these compounds remains unclear [3]. The production of spermidine from putrescine, or spermine from spermidine, consumes the amino acid Met in a 1:1 stoichiometry yielding methylthioadenosine (MTA) as a byproduct. As Met biosynthesis is energetically expensive, and many organisms lack the ability to synthesize the amino acid, a unique pathway exists which recycles Met from MTA. To date, the entire pathway has only been fully characterised in the Gram-negative bacterium Klebsiella pneumoniae [5-11] and the Gram-positive bacterium Bacillus subtilis [12-14] Selected individual enzymes active in the pathway have been studied in a wide variety of eukaryotic and prokaryotic organisms [7,15-20]. For Mycobacterium spp., only methionine adenosyltransferase has been cloned, expressed, and fully characterised [21].
###end p 10
###begin p 11
###xml 279 292 279 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae</italic>
###xml 294 305 294 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis</italic>
###xml 311 324 311 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 359 380 359 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 382 407 382 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trypanosoma brucei brucei</italic>
###xml 409 429 409 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Giardia intestinalis</italic>
###xml 435 456 435 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crithidia fasciculata</italic>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 548 561 548 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae</italic>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 793 804 793 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis</italic>
###xml 806 815 806 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. cereus</italic>
###xml 821 834 821 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1103 1115 1103 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 1119 1128 1119 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. cereus</italic>
###xml 1129 1142 1129 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 1223 1242 1223 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium spp. </italic>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1359 1375 1359 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1534 1549 1534 1549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 279 292 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 294 305 <span type="species:ncbi:1423">B. subtilis</span>
###xml 311 323 <span type="species:ncbi:1392">B. anthracis</span>
###xml 359 380 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 382 407 <span type="species:ncbi:5702">Trypanosoma brucei brucei</span>
###xml 409 429 <span type="species:ncbi:5741">Giardia intestinalis</span>
###xml 435 456 <span type="species:ncbi:5656">Crithidia fasciculata</span>
###xml 548 561 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 793 804 <span type="species:ncbi:1423">B. subtilis</span>
###xml 806 815 <span type="species:ncbi:1396">B. cereus</span>
###xml 821 833 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1103 1114 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1119 1128 <span type="species:ncbi:1396">B. cereus</span>
###xml 1129 1141 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1359 1374 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1534 1549 <span type="species:ncbi:1773">M. tuberculosis</span>
The final step in Met regeneration is the transamination of ketomethiobutyrate (KMTB) by an aminotransferase. The specific aminotransferase responsible for the reaction has been identified and characterised in a number of microorganisms, including malaria, African trypanosomes, K. pneumoniae, B. subtilis, and B. anthracis [7,16,17]. In the lower eukaryotes Plasmodium falciparum, Trypanosoma brucei brucei, Giardia intestinalis, and Crithidia fasciculata, this reaction is catalysed by the subfamily Ia enzyme aspartate aminotransferase [17]. In K. pneumoniae, however, the reaction was performed by the close homologue tyrosine aminotransferase, which is also a member of subfamily Ia [7]. Gram-positive bacteria and archaea appear to lack any subfamily Ia homologues in their genomes, and B. subtilis, B. cereus, and B. anthracis were recently found to catalyse Met regeneration via a branched-chain amino acid aminotransferase (BCAT) [16]. This enzyme is a member of family III, along with D-amino acid aminotransferase (DAAT), and is unrelated structurally to family I enzymes [22]. Intriguingly, B. subtilis and B. cereus/B. anthracis utilised BCAT enzymes from separate subfamilies (IIIa vs. IIIb respectively). As Mycobacterium spp. also appear to have no subfamily Ia aminotransferase sequences ([16], and data not shown), it would be expected that M. tuberculosis also catalyses the conversion of KMTB to Met via a BCAT. In this paper, we report the identification, cloning, and functional expression of a single BCAT from M. tuberculosis. In addition, this enzyme has been demonstrated to actively catalyse Met formation and is subject to inhibition by a variety of aminooxy compounds.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 46 61 46 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 46 61 <span type="species:ncbi:1773">M. tuberculosis</span>
Branched-chain amino acid aminotransferase in M. tuberculosis
###end title 13
###begin p 14
###xml 34 50 34 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 136 148 136 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 287 299 287 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 305 315 305 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. cereus </italic>
###xml 324 337 324 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 557 573 557 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 689 705 689 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 34 55 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 136 147 <span type="species:ncbi:1423">B. subtilis</span>
###xml 287 298 <span type="species:ncbi:1423">B. subtilis</span>
###xml 305 314 <span type="species:ncbi:1396">B. cereus</span>
###xml 324 336 <span type="species:ncbi:1392">B. anthracis</span>
###xml 557 572 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 689 704 <span type="species:ncbi:1773">M. tuberculosis</span>
The complete, published genome of M. tuberculosis H37Rv was found to contain a single gene with a very high sequence homology to either B. subtilis YbgE or YwaA, which are both known to be subfamily IIIa BCATs [16,23]. In contrast, the tuberculosis genome did not contain a homologue to B. subtilis YheM, B. cereus BCAT, or B. anthracis BCAT, which are all subfamily IIIb aminotransferases [16]. This relationship can be clearly seen in Figure 2A, where selected family III aminotransferases have been aligned and an unrooted tree constructed. The putative M. tuberculosis BCAT gene, Rv2210c, has not been previously cloned, expressed, or characterised. It is interesting to note that the M. tuberculosis genome contains a single BCAT homologue and no obvious DAAT homologue.
###end p 14
###begin p 15
###xml 59 76 59 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium spp</italic>
###xml 105 114 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. leprae</italic>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. bovis</italic>
###xml 126 136 126 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum</italic>
###xml 138 149 138 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. ulcerans</italic>
###xml 151 159 151 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. avium</italic>
###xml 165 178 165 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 372 388 372 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 392 401 392 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. bovis </italic>
###xml 439 450 439 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 454 466 454 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. ulcerans </italic>
###xml 488 496 488 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. bovis</italic>
###xml 578 594 578 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 683 707 683 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces coelicolor </italic>
###xml 728 740 728 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1009 1017 1009 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1034 1047 1034 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 1064 1076 1064 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 105 114 <span type="species:ncbi:1769">M. leprae</span>
###xml 116 124 <span type="species:ncbi:1765">M. bovis</span>
###xml 126 136 <span type="species:ncbi:1781">M. marinum</span>
###xml 138 149 <span type="species:ncbi:1809">M. ulcerans</span>
###xml 151 159 <span type="species:ncbi:1764">M. avium</span>
###xml 165 177 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 372 387 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 392 400 <span type="species:ncbi:1765">M. bovis</span>
###xml 439 449 <span type="species:ncbi:1781">M. marinum</span>
###xml 454 465 <span type="species:ncbi:1809">M. ulcerans</span>
###xml 488 496 <span type="species:ncbi:1765">M. bovis</span>
###xml 578 593 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 683 706 <span type="species:ncbi:1902">Streptomyces coelicolor</span>
###xml 728 739 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1009 1016 <span type="species:ncbi:562">E. coli</span>
###xml 1034 1046 <span type="species:ncbi:1392">B. anthracis</span>
###xml 1064 1075 <span type="species:ncbi:1423">B. subtilis</span>
Examination of complete and incomplete genome projects for Mycobacterium spp. uncovered a single gene in M. leprae, M. bovis, M. marinum, M. ulcerans, M. avium, and M. smegmatis with an extremely high identity to Rv2110c. Together, with other subfamily IIIa aminotransferases, the putative mycobacterial sequences were aligned and a cladogram constructed (Figure 2B). The M. tuberculosis and M. bovis sequences were identical, as were the M. marinum and M. ulcerans sequences. Aside from M. bovis, all the mycobacterial BCAT sequences were found to be 85 - 88% identical to the M. tuberculosis sequence. However, the tuberculosis sequence was 57% identical to the putative BCAT from Streptomyces coelicolor and 45% identical to B. subtilis YbgE. Figure 2B highlights the fact that the mycobacterial BCAT sequences are more closely related to eukaryotic enzymes than to most other bacterial homologues. There was little sequence conservation with enzymes found in subfamily IIIb, with only 27% identity to the E. coli BCAT, 18% to the B. anthracis BCAT, and 15% to B. subtilis YheM.
###end p 15
###begin p 16
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 325 333 325 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 790 798 790 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 325 332 <span type="species:ncbi:562">E. coli</span>
###xml 499 506 <span type="species:ncbi:562">E. coli</span>
###xml 790 797 <span type="species:ncbi:562">E. coli</span>
The low level of sequence conservation outside of the genus can be seen in the alignment of selected BCAT sequences shown in Figure 3. Only 19 residues are completely conserved across even this small sequence sampling. Interestingly, of the residues found by X-ray crystallography to be important in substrate binding to the E. coli BCAT [24], only K228(K159) and T339(T257) were conserved across the 13 sequences in Figure 3. The residues in parentheses represent the corresponding position in the E. coli BCAT. Of these two residues, K228(K159) is the PLP binding site and would be expected to be invariant. If one excludes the only DAAT in Figure 3, then Y91(Y31), F96(36), Y233(164), and A340(A258) can be added to this conserved list of residues important for substrate binding in the E. coli BCAT. Clearly, sequence conservation is very low across family III.
###end p 16
###begin title 17
Expression and characterization of the branched-chain amino acid aminotransferase
###end title 17
###begin p 18
###xml 13 29 13 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 366 369 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 394 395 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 13 28 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 98 105 <span type="species:ncbi:562">E. coli</span>
The putative M. tuberculosis BCAT was cloned as a deca-histidine fusion protein for expression in E. coli. To prevent complete inclusion of the recombinant protein, it was necessary to induce expression with a relatively low concentration of IPTG (0.1 mM) at 20degreesC for 20 hr. Under these conditions, sufficient soluble material was produced and purified over Ni2+ affinity columns (Figure 4). Assay of the eluted material with 2 mM each of ADEFGHIKLNQRSTVWY and 1 mM KMTB resulted in appreciable Met production (data not shown), demonstrating that the enzyme was active and catalysed Met formation.
###end p 18
###begin p 19
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 936 937 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1199 1211 1197 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 1273 1275 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1199 1210 <span type="species:ncbi:1423">B. subtilis</span>
The purified enzyme was screened against 2 mM of each individual amino acid and 1 mM KMTB to determine the amino donor range for Met regeneration. Isoleucine, leucine, and valine were found to be the most effective substrates (Figure 5), while glutamate and phenylalanine were also active as amino donors. Tyrosine and tryptophan were found to have a much lesser ability to transaminate KMTB and all other amino acids were inactive. The five most active amino donors were more closely examined in order to determine their kinetic parameters (Table 1). The Km for Leu, Ile, and Val ranged from 1.77 - 2.85 mM, while that for Glu was 9.53 mM and Phe 7.44 mM. The Vmax for all five amino acids was similar at 2.17 - 5.70 mumol/min/mg protein. KMTB was found to have a Km of 4.20 mM. The enzyme was also examined for branched-chain amino acid and KG aminotransfer in order characterise the "classic" reactions associated with a BCAT (Table 1). The Km of the substrates was found to be similar, while the Vmax ranged from 11.82 - 14.35 mumol/min/mg protein. Therefore, the tuberculosis BCAT catalyses aminotransfer of KG about 3 times more readily than KMTB. This result is similar to that seen with the B. subtilis BCAT, which also transaminates KG at a higher rate than KMTB [16].
###end p 19
###begin title 20
Inhibition studies
###end title 20
###begin p 21
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 553 555 553 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 799 802 799 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ic </sub>
###xml 865 868 864 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink">iu </sub>
Thirteen aminooxy compounds were assayed for inhibitory effects on the tuberculosis BCAT. The enzyme was incubated with 2.0 mM leucine, 1.0 mM KMTB and 0.1 or 1.0 mM inhibitor to assay for the effect on Met regeneration (Figure 6). With the exception of O-trimethylsilylhydroxylamine, all of the compounds inhibited Met formation to some extent. The four most active compounds at 0.1 mM were O-allylhydroxylamine, carboxymethoxylamine, O-benzylhydroxylamine, and O-t-butylhydroxylamine, and these inhibitors were further examined in order to determine Ki values (Table 2). For all four compounds, the inhibition data was not consistent with a simple competitive or uncompetitive model, but fit very well with a model of mixed mode inhibition [25]. The competitive component of inhibition yielded a Kic of 8.20 - 21.61 muM, while the uncompetitive component gave a Kiu of 84.08 - 386 muM. Therefore, the inhibition of the tuberculosis BCAT by these four aminooxy compounds is primarily competitive.
###end p 21
###begin p 22
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 197 213 197 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 217 228 217 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 284 295 284 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 318 334 318 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 391 407 391 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 711 712 711 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 765 768 764 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 1081 1083 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1084 1086 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1204 1220 1201 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1224 1235 1221 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 1322 1338 1319 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1398 1409 1394 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 197 212 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 217 227 <span type="species:ncbi:1781">M. marinum</span>
###xml 284 294 <span type="species:ncbi:1781">M. marinum</span>
###xml 318 333 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 391 406 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 460 466 <span type="species:ncbi:9606">humans</span>
###xml 1204 1219 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1224 1234 <span type="species:ncbi:1781">M. marinum</span>
###xml 1322 1337 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1398 1408 <span type="species:ncbi:1781">M. marinum</span>
These four inhibitors and canaline, an aminooxy analogue of ornithine that has been demonstrated to be an effective aminotransferase inhibitor in other systems [16,17,26-28], were screened against M. tuberculosis and M. marinum in vitro to determine potential antimicrobial activity. M. marinum is a close relative of M. tuberculosis that causes a similar disease in fish, grows faster than M. tuberculosis in culture, and does not cause serious infections in humans [29]. As such, it is an excellent surrogate for the initial screening of antimycobacterial agents, and we wished to validate its use for aminooxy compounds. All the inhibitors were found to have some degree of antimycobacterial activity (Table 3), with MIC values ranging from 78 muM - 10 mM and IC50 values of 8.49 muM - 467 muM. The best inhibitor was found to be O-allylhydroxylamine. While O-t-butylhydroxylamine and O-benzylhydroxylamine appeared to be the best enzyme inhibitors, they were significantly less effective than O-allylhydroxylamine as growth inhibitors. Unlike other organisms examined to date [27,30], canaline was not a particularly good inhibitor of both enzyme activity and cell growth. The inhibition results for M. tuberculosis and M. marinum were very similar, with MIC results being identical or within 1 dilution. In addition, M. tuberculosis was found to have an MIC of 2 mug/ml for streptomycin while M. marinum had one of 8 mug/ml.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 218 229 218 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis</italic>
###xml 231 240 231 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. cereus</italic>
###xml 246 259 246 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 299 312 299 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus spp.</italic>
###xml 388 400 388 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 404 413 404 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. cereus</italic>
###xml 414 427 414 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 581 592 581 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis</italic>
###xml 594 610 594 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 784 800 784 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 940 952 939 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 1042 1044 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1164 1180 1161 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1248 1260 1244 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 1266 1268 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1467 1475 1463 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1521 1523 1517 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1524 1526 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1527 1529 1523 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1617 1633 1613 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1777 1793 1773 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 2046 2047 2042 2043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2171 2187 2167 2183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 2194 2206 2190 2202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 218 229 <span type="species:ncbi:1423">B. subtilis</span>
###xml 231 240 <span type="species:ncbi:1396">B. cereus</span>
###xml 246 258 <span type="species:ncbi:1392">B. anthracis</span>
###xml 388 399 <span type="species:ncbi:1423">B. subtilis</span>
###xml 404 413 <span type="species:ncbi:1396">B. cereus</span>
###xml 414 426 <span type="species:ncbi:1392">B. anthracis</span>
###xml 581 592 <span type="species:ncbi:1423">B. subtilis</span>
###xml 594 609 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 784 799 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 940 951 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1164 1179 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1248 1259 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1467 1474 <span type="species:ncbi:562">E. coli</span>
###xml 1495 1500 <span type="species:ncbi:9606">human</span>
###xml 1617 1632 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1658 1663 <span type="species:ncbi:9606">human</span>
###xml 1777 1792 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1805 1810 <span type="species:ncbi:9606">human</span>
###xml 1946 1951 <span type="species:ncbi:9606">human</span>
###xml 2171 2186 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2194 2205 <span type="species:ncbi:1423">B. subtilis</span>
The specific aminotransferase involved in the formation of Met from KMTB has been examined in a number of eukaryotic and prokaryotic organisms [7,16,17]. However, within the low-GC content Gram-positive bacteria, only B. subtilis, B. cereus, and B. anthracis have been studied [16]. In all of these Bacillus spp., a BCAT has been found to be responsible for catalysing the reaction, with B. subtilis and B. cereus/B. anthracis utilising enzymes from different aminotransferase subfamilies. No member of the high-GC content Gram-positive bacteria has been previously examined. Like B. subtilis, M. tuberculosis has been found to catalyse Met regeneration using a subfamily IIIa aminotransferase. In fact, the kinetic parameters for the two aminotransferases were almost identical. The M. tuberculosis BCAT had Km values of 1.77 - 2.85 mM and Vmax values of 2.58 - 4.28 mumol/min/mg protein for branched-chain amino acids and KMTB, while the B. subtilis YbgE had the corresponding values of 2.36 - 3.20 mM and 1.84 - 2.03 mumol/min/mg protein [16]. For branched-chain amino acids and KG, the values were 5.79 - 6.16 mM and 11.82 - 14.35 mumol/min/mg protein for the M. tuberculosis BCAT, and 2.82 - 3.99 mM and 13.93 - 16.61 mumol/min/mg protein for B. subtilis YbgE [16]. Therefore, a 45% sequence identity between the two enzymes is sufficient to conserve both the substrate range and kinetic properties of the BCATs. Structural information is only available for the E. coli BCAT (IlvE) and the human mitochondrial BCAT [24,24,31], but the key residues involved in substrate specificity appear to be conserved in the M. tuberculosis BCAT. However, while the human mitochondrial BCAT is also a family IIIa aminotransferase, there are some clear differences when compared to the M. tuberculosis enzyme. The human enzyme will not accept aromatic amino acids, whereas the tuberculosis BCAT would use phenylalanine as an amino donor. In addition, the human enzyme contains the redox-active motif CXXC at positions 311-314 (positions 341-344 in Figure 3) which is essential for maintaining activity, while the tuberculosis BCAT lacks these residues. Structural analysis of the M. tuberculosis and/or B. subtilis enzymes would clarify these issues.
###end p 24
###begin p 25
###xml 4 20 4 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 701 715 701 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus spp. </italic>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 4 19 <span type="species:ncbi:1773">M. tuberculosis</span>
The M. tuberculosis BCAT was also screened with a variety of aminooxy compounds as potential inhibitors. These compounds are known aminotransferase inhibitors and act by forming a stable Schiff-base with the PLP cofactor [32]. Unlike previous studies [7,16,17,33], canaline was not found to be one of the better inhibitors of aminotransferase activity. Instead, O-benzylhydroxylamine, O-t-butylhydroxylamine, carboxymethoxylamine, and O-allylhydroxylamine were the most efficient inhibitors of Met formation from KMTB. In addition, these compounds demonstrated mixed type inhibition with a lower Ki for the competitive component. This result contrasts with that previously found for canaline with the Bacillus spp. enzymes, where inhibition was uncompetitive [16]. It may be possible that this difference may be due to the structure of the inhibitors, as canaline is a gamma-substituted amino acid analogue, while the present inhibitors are alpha-substituted or non-amino acid analogues. Essentially, the inhibitors examined in this study do not present an alpha-amino group suitable for participation in the transamination reaction whereas canaline does.
###end p 25
###begin p 26
###xml 44 60 44 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 64 75 64 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 210 226 210 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 230 241 230 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 518 529 518 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 608 624 608 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 44 59 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 64 74 <span type="species:ncbi:1781">M. marinum</span>
###xml 210 225 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 230 240 <span type="species:ncbi:1781">M. marinum</span>
###xml 518 528 <span type="species:ncbi:1781">M. marinum</span>
###xml 608 623 <span type="species:ncbi:1773">M. tuberculosis</span>
Further screening of the inhibitors against M. tuberculosis and M. marinum in vitro demonstrated that the compounds can act as effective antimycobacterial agents. The close correspondence of the MIC values for M. tuberculosis and M. marinum validates the use of the latter organism as a more rapid and safe initial screen of the antimycobacterial properties of aminooxy compounds. The MIC values found for streptomycin against these two organisms was also found to be consistent with previously published values [34]. M. marinum can thus be used to quickly test a larger number of potential inhibitors, with M. tuberculosis used as a follow up for more promising candidates.
###end p 26
###begin p 27
###xml 99 115 99 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 134 137 134 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 496 507 495 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 527 542 525 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 99 114 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 496 506 <span type="species:ncbi:1781">M. marinum</span>
###xml 527 542 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
Interestingly, there was no direct correlation between the Ki of the compounds against recombinant M. tuberculosis BCAT and the MIC/IC50 against cell growth. It is possible that there may be differences in the uptake rate of the various compounds into viable cells. Alternatively, the most effective growth inhibitors act by inhibiting other PLP-dependent enzymes in addition to BCAT. In any case, O-allylhydroxylamine was the most effective antimycobacterial agent with an MIC of 78 muM against M. marinum and 156 muM against M. tuberculosis. Unfortunately, the compound is corrosive, and is thus unsuitable for further in vivo study. However, the structure of the compound might provide the basis for the design of less toxic, more active structural analogues. In future studies, it will be necessary to examine the effect of potential inhibitors on human BCAT, in order to better assess the potential for host toxicity. Any further development of aminooxy compounds as antimycobacterial agents will depend on discovering a selective inhibitor for the microbial enzyme.
###end p 27
###begin p 28
###xml 98 114 98 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 324 326 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 344 346 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 361 363 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 838 853 833 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1017 1019 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1094 1110 1089 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1219 1234 1214 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 98 113 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 838 853 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 901 905 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1094 1109 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1219 1234 <span type="species:ncbi:1773">M. tuberculosis</span>
Several older studies have been conducted on the antimicrobial effect of aminooxy compounds, with M. tuberculosis included amongst the organisms tested [35-39]. From these papers, the only compound in common with the present study was carboxymethoxylamine, which was found to have an MIC of 313 muM (present data), 910 muM [35], 170 - 686 muM [36], or 170 muM [37]. Given the variety of media used in these studies for determining the MIC value, the results are quite consistent. The variety of non-commercially available aminooxy compounds synthesized and tested in these older studies included aminooxy acids, aminooxy amides, aminooxy hydroxamic acids, aminooxy hydrazides, aminooxy alkanes, and aminooxy guanidines. Several of these compounds were very effective growth inhibitors in vitro, with MIC values as low as 0.30 muM against M. tuberculosis. One of the compounds has been administered to mice, with favourable, albeit sparsely detailed, results with regard to toxicity and in vivo antitubercular effect [38]. While it is unclear what effect these inhibitors would have against the M. tuberculosis BCAT, it would appear to be possible to design more effective, less toxic aminooxy compounds for use against M. tuberculosis.
###end p 28
###begin p 29
###xml 89 105 89 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 229 241 229 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 569 581 569 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 626 638 626 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 755 768 755 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 964 980 964 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 995 996 995 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 89 104 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 229 240 <span type="species:ncbi:1423">B. subtilis</span>
###xml 569 580 <span type="species:ncbi:1423">B. subtilis</span>
###xml 626 637 <span type="species:ncbi:1423">B. subtilis</span>
###xml 755 767 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 964 979 <span type="species:ncbi:1773">M. tuberculosis</span>
Several interesting findings arose during the course of this investigation. First, while M. tuberculosis has only the one branched-chain aminotransferase, it does contain a coding sequence (Rv0858c) with a high similarity to the B. subtilis ykrV gene product. YkrV was found to be a subfamily If aminotransferase and could also catalyse the conversion of KMTB to Met using glutamine as the only effective amino donor [16]. Therefore, it is possible that the Rv0858c gene product might be capable of KMTB transamination. It should be stressed that while the recombinant B. subtilis YkrV could transaminate KMTB with glutamine, B. subtilis cell homogenates did not produce Met from KMTB when supplemented with glutamine [16]. Similarly, cell homogenates of M. smegmatis grown in Middlebrook 7H9 incomplete medium were only able to produce Met from KMTB when supplemented with valine, isoleucine, leucine, glutamate, or phenylalanine, as was seen for the recombinant M. tuberculosis BCAT in figure 5 (data not shown).
###end p 29
###begin p 30
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 465 481 465 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 465 480 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis was found to contain no putative gene product with significant homology to a DAAT. In fact, the organism appeared to contain no subfamily IIIb aminotransferases. The physiological significance of a lack of a DAAT is unclear, but many organisms do not contain a homologue of this enzyme. With DAAT, there might be a diminished capacity to catabolise D-amino acids for energy, although the same reactions could be performed by a D-amino acid oxidase. M. tuberculosis is known to be reliant on carbohydrate catabolism during the active growth phase and lipid metabolism during the chronic, dormant phase [40]. Therefore, the lack of a DAAT might be reflective of a lifestyle where protein and peptide catabolism is relatively unimportant.
###end p 30
###begin p 31
###xml 11 27 11 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 242 258 242 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 431 447 431 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 593 602 593 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. bovis </italic>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 844 860 844 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 992 1006 992 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 1010 1021 1010 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis</italic>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1213 1235 1213 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseduomonas aeruginosa</italic>
###xml 1237 1255 1237 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xylella fastidiosa</italic>
###xml 1257 1279 1257 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leptospira interrogans</italic>
###xml 1285 1318 1285 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermoanaerobacter tengcongensis </italic>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1600 1616 1600 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1754 1769 1754 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 11 26 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 242 257 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 431 446 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 593 601 <span type="species:ncbi:1765">M. bovis</span>
###xml 844 859 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 992 1005 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 1010 1021 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1237 1255 <span type="species:ncbi:2371">Xylella fastidiosa</span>
###xml 1257 1279 <span type="species:ncbi:173">Leptospira interrogans</span>
###xml 1285 1317 <span type="species:ncbi:119072">Thermoanaerobacter tengcongensis</span>
###xml 1600 1615 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1754 1769 <span type="species:ncbi:1773">M. tuberculosis</span>
Similarly, M. tuberculosis was found to lack clearly identifiable homologues of several enzymes in the Met regeneration pathway. The most glaring omission is the lack of an S-adenosylmethionine decarboxylase (SAMdc) homologue (see Figure 1). M. tuberculosis contains the preceding enzyme, methionine adenosyltransferase [21], and has an easily identifiable homologue for the succeeding enzyme, spermidine synthase [23]. Therefore, M. tuberculosis must catalyse SAMdc activity via another enzyme in order to be able to synthesize polyamines. A previous study has demonstrated SAMdc activity in M. bovis homogenates, but has not identified the enzyme responsible [41]. Resolution of this issue is critical for a more complete understanding of polyamine biosynthesis in tuberculosis, and may yield a novel enzyme as an additional drug target. The M. tuberculosis genome also appears to be missing homologues of the enzymes converting methylthioribose to KMTB (see Figure 1). However, outside of K. pneumoniae and B. subtilis, these enzymes have not been well studied, and, between these two organisms, there are key differences in the enzymes catalyzing several steps [12,20]. In silico analyses have suggested that Pseduomonas aeruginosa, Xylella fastidiosa, Leptospira interrogans, and Thermoanaerobacter tengcongensis have readily identifiable, complete Met regeneration pathways [42]. However, the presence or absence of the pathway in a variety of prokaryotic and eukaryotic organisms remains to be determined by functional analysis. Therefore, there is much left to examine before concluding that M. tuberculosis contains neither homologues nor analogues to these Met recycling enzymes. However, even in the absence of a complete Met salvage pathway, M. tuberculosis, as an intracellular pathogen, might utilise exogenous KMTB as a Met source.
###end p 31
###begin title 32
Conclusions
###end title 32
###begin p 33
###xml 82 97 82 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 331 347 331 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 350 361 350 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 82 97 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 331 346 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 350 360 <span type="species:ncbi:1781">M. marinum</span>
Branched-chain amino acid aminotransferase has been cloned and characterised from M. tuberculosis. This enzyme was found to be responsible for the formation of methionine from ketomethiobutyrate, and could be inhibited in vitro by a series of aminooxy compounds. Several of these compounds were found to be effective inhibitors of M. tuberculosis or M. marinum growth in culture, with MIC values as low as 156 muM and 78 muM respectively. These studies demonstrate the importance branched-chain amino acid and methionine metabolism to the survival of mycobacteria, and open up the potential for the development of more potent and less toxic aminooxy inhibitors of the branched-chain aminotransferase.
###end p 33
###begin title 34
Methods
###end title 34
###begin title 35
Cells and reagents
###end title 35
###begin p 36
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 159 175 153 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 193 203 181 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum</italic>
###xml 0 21 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 26 36 <span type="species:ncbi:1781">M. marinum</span>
###xml 159 174 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 193 203 <span type="species:ncbi:1781">M. marinum</span>
M. tuberculosis H37Rv and M. marinum Aronson (ATCC927) were cultured in liquid Middlebrook 7H9 complete medium or on Middlebrook 7H10 plates at 37degreesC for M. tuberculosis or 30degreesC for M. marinum. All substrates and inhibitors were obtained from Sigma-Aldrich (Oakville, ON, Canada).
###end p 36
###begin title 37
Cloning and functional expression
###end title 37
###begin p 38
###xml 30 46 30 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 30 45 <span type="species:ncbi:1773">M. tuberculosis</span>
Genomic DNA was isolated from M. tuberculosis by vortexing packed cells in a minimal volume of 50 mM Tris-HCl pH 8.0/10 mM EDTA/100 mM NaCl containing 500 mum acid washed glass beads (Sigma). After allowing the glass beads to settle, the supernatant was added to an equal volume of 10 mM Tris-HCl pH 8.0/100 mM NaCl/25 mM EDTA/0.5% w/v sodium dodecyl sulfate/0.1 mg/ml proteinase K and incubated for 1 hr at 37degreesC with occasional gentle mixing. The mixture was then subjected to extraction with phenol:chloroform:isoamyl alcohol (25:24:1), and the DNA ethanol precipitated.
###end p 38
###begin p 39
###xml 29 45 29 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 104 120 104 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 143 155 143 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1340 1357 1310 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 29 44 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 104 125 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 143 154 <span type="species:ncbi:1423">B. subtilis</span>
###xml 1340 1356 <span type="species:ncbi:562">Escherichia coli</span>
The sequence of the putative M. tuberculosis BCAT gene was discovered by a BLAST search of the complete M. tuberculosis H37Rv genome using the B. subtilis YbgE, YwaA, or YheM gene products as the query proteins [16,23,43]. The single resulting putative BCAT gene was used to construct oligonucleotide primers for PCR amplification. The 5' primer was TCGAGGCGGCCGCAAATGACCAGCGGCTCCCTTCA and incorporated a NotI restriction site and an in-frame start codon. The 3' primer was ATCGAGCTCGAGTTACCCCAGCCGCGCCATCCAG and incorporated a XhoI restriction site and an in-frame stop codon. The BCAT gene was then amplified using a 5:1 mixture of Taq:Pfu polymerases (Promega; Madison, WI, USA) and the following program: 1 cycle of 95degreesC for 1.5 min; 30 cycles of 95degreesC for 1 min, 55degreesC for 1 min, and 72degreesC for 1 min; and 1 cycle of 72degreesC for 10 min. The resulting PCR product was excised from a 1% agarose gel and recovered using the Qiaex II kit (Qiagen; Mississauga, ON, Canada). The purified product was digested with NotI and XhoI and ligated into a similarly digested pET 19 m (a modification by us of pET19b (Novagen; Madison, WI, USA) to incorporate extra restriction sites in the multiple cloning site) using a Rapid Ligation kit (Fermentas; Burlington, ON, Canada). The recombinant plasmid was then transformed into Escherichia coli XL10 cells (Stratagene; La Jolla, CA, USA) and was subsequently recovered using the Qiaspin miniprep kit (Qiagen). Positive clones were determined by digesting the plasmid with NotI and XhoI to confirm the presence of the insert on a 1% agarose gel. The sequence of the insert was confirmed by using the Big-Dye cycle sequencing kit (ABI; Foster City, CA, USA) and an ABI Prism 310 genetic analyser.
###end p 39
###begin p 40
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 287 294 279 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 nm </sub>
###xml 54 66 <span type="species:ncbi:511693">E. coli BL21</span>
The plasmid from positive clones was transformed into E. coli BL21(DE3) CodonPlus RIL cells (Stratagene) for functional expression. Cells were grown in liquid LB medium containing 50 mug/ml ampicillin and 50 mug/ml chloramphenicol at 37degreesC and 250 rpm until the culture reached an A600 nm of 0.6-0.8. The culture was then cooled to 20degreesC for 30 min at 250 rpm before the addition of 0.1 mM isopropylthiogalactopyranoside (IPTG) and an additional 20 hr of incubation at 20degreesC and 250 rpm.
###end p 40
###begin p 41
###xml 406 407 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
The culture was centrifuged at 3500 x g for 20 min at 4degreesC, and the cell pellet resuspended in 50 mM HEPES (pH 7.4)/750 mM NaCl and frozen at -20degreesC. The resuspended cells were then thawed, sonicated on ice, centrifuged at 3000 x g for 20 min at 4degreesC, and the supernatant loaded onto a 1.6 x 9.5 Chelating-Sepharose-FF column (Amersham Biosciences; Baie d'Urfe, QC, Canada) charged with NiSO4. The column was washed with 50 mM HEPES (pH 7.4)/750 mM NaCl and 50 mM HEPES (pH 7.4)/750 mM NaCl/80 mM imidazole, before elution with 50 mM HEPES (pH 7.4)/750 mM NaCl/800 mM imidazole. Fractions containing the recombinant protein were pooled and concentrated to less than 3.0 ml using a 30 kDa molecular mass cut-off filter (Pall Filtron; Mississauga, ON, Canada). The concentrated enzyme was then dialysed against 50 mM HEPES (pH 7.4)/1 mM dithiothreitol/1 mM EDTA/trace pyridoxal-5-phosphate (PLP) overnight at 4degreesC. The concentrated enzymes were stored at 4degreesC for several days, or with 20% v/v glycerol at -20degreesC for several weeks, without appreciable loss of activity. Recombinant protein samples were examined by electrophoresis on 10% SDS polyacrylamide gels followed by Coomassie Brilliant Blue R250 staining. Protein concentration was measured using the Bio-Rad reagent (Bio-Rad; Mississauga, ON, Canada).
###end p 41
###begin title 42
Enzyme assays and inhibition studies
###end title 42
###begin p 43
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 147 149 145 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
Aminotransferase activities were assayed by an HPLC method [17]. 5 or 10 mul of recombinant enzyme was added to 100 mul of substrate mix (100 mM PO4 (pH 7.4)/50 muM PLP/various concentrations of amino acid/various concentrations of keto acid) and incubated for 30 min at 37degreesC. The samples were then stored at -20degreesC until analysis by HPLC. All samples were analysed by pre-column derivatisation and reverse-phase HPLC. 10 mul of sample was mixed with 50 mul of 400 mM borate pH 10.5 and then with 10 mul of 10 mg/ml o-phthalaldehyde/12 mul/ml mercaptopropionate/400 mM borate pH 10.5 prior to the injection of 7.0 mul onto a 2.1 x 200 mm ODS-AA column (Agilent; Mississauga, ON, Canada). The column was eluted using 2.72 mg/ml sodium acetate pH 7.2/0.018% v/v triethylamine/0.3% v/v tetrahydrofuran as Buffer A and 2.72 mg/ml sodium acetate pH 7.2/40% v/v methanol/40% v/v acetonitrile as Buffer B with a linear gradient of 0 - 17% B over 16 min followed by a linear gradient of 17-100% B over 1 min and 6.0 min at 100% B. The flow rate was 0.45 ml/min from 0 - 16 min and 0.80 ml/min from 17-30 min. The elution of derivatised amino acids was monitored at 338 nm and fluorometrically with an excitation of 338 nm and an emission of 450 nm. All separations were performed on an Agilent 1100 HPLC equipped with an autosampler, variable wavelength ultraviolet/visible spectrophotometric detector, fluorescence detector, and Chemstation operating system.
###end p 43
###begin p 44
The amino donor range for Met regeneration was determined by incubating 2 mM of each individual amino acid and 1 mM KMTB, followed by HPLC for Met quantification. Amino acids which were effective amino donors were further studied at 0.1 - 10 mM amino acid and 10 mM KMTB to determine the kinetic constants. Similar assays were performed with 0.1 - 10 mM KMTB and 10 mM Leu. Replacement of KMTB with ketoglutarate (KG) in these experiments and subsequent HPLC analysis of Glu formation allowed for the determination of BCAT activity. The apparent Km and Vmax values for each substrate were assessed by non-linear curve fitting using the Scientist software programmed with the Michaelis-Menton equation (Micromath; Salt Lake City, UT, USA).
###end p 44
###begin p 45
###xml 66 82 66 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 309 311 309 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 479 481 478 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 636 638 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 66 81 <span type="species:ncbi:1773">M. tuberculosis</span>
Initial inhibition studies screened 13 aminooxy compounds against M. tuberculosis BCAT using 2.0 mM Leu/1.0 mM KMTB/0.1 or 1.0 mM inhibitor in the enzyme incubation. Inhibitors which demonstrated better than 50% reduction of activity at the 0.1 mM concentration were further studied for the determination of Ki values. These reactions involved 0.5, 1.0, 2.0, or 3.0 mM Leu and 1.0 mM KMTB in the reaction mixture together with 0, 25, 50, 75, 100, 150, 200 muM of inhibitor. The Ki values were determined by non-linear curve fitting with the Scientist software programmed with competitive, uncompetitive, and mixed inhibition equations [25].
###end p 45
###begin p 46
###xml 53 69 53 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 73 84 73 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 211 213 211 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 563 573 554 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum</italic>
###xml 602 617 587 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 670 677 655 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink">650 nm </sub>
###xml 850 853 835 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 959 961 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 53 68 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 73 83 <span type="species:ncbi:1781">M. marinum</span>
###xml 563 573 <span type="species:ncbi:1781">M. marinum</span>
###xml 602 617 <span type="species:ncbi:1773">M. tuberculosis</span>
In vitro growth inhibition studies were performed on M. tuberculosis and M. marinum using the most effective enzyme inhibitors. Cultures at mid-log growth in Middlebrook 7H9 complete medium was diluted to 2 x 105 cfu/ml and 100 mul added to 96 well microtitre plates containing 100 mul of doubling dilutions of each inhibitor. The final inhibitor concentration ranged from 10 mM - 298 pM. Positive and negative controls consisted of 100 mul Middlebrook 7H9 medium replacing the inhibitor or cells respectively. The plates were incubated at 30degreesC for 8 days (M. marinum) or 37degreesC for 14 days (M. tuberculosis) with no agitation before measurement of growth at A650 nm using a Molecular Devices 96-well spectrophotometer (Sunnyvale, CA, USA). The MIC was determined as the lowest dilution that completely prevented microbial growth and the IC50 was determined by non-linear curve fitting with the Scientist software programmed with the Chou equation [44].
###end p 46
###begin title 47
Phylogenetic analysis
###end title 47
###begin p 48
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 68 87 68 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium spp. </italic>
###xml 200 213 200 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. avium</italic>
###xml 255 265 255 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum</italic>
###xml 302 313 302 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. ulcerans</italic>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 200 212 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 217 225 <span type="species:ncbi:1764">M. avium</span>
###xml 255 265 <span type="species:ncbi:1781">M. marinum</span>
###xml 302 313 <span type="species:ncbi:1809">M. ulcerans</span>
Additional BCAT and DAAT sequences were obtained from GenBank [38]. Mycobacterium spp. BCAT sequences from preliminary genome projects were made available from The Institute for Genomic Research  for M. smegmatis and M. avium, from The Sanger Centre  for M. marinum, and from The Institut Pasteur  for M. ulcerans. These sequences were aligned using the Clustal algorithm and the BLOSUM sequence substitution table in the ClustalX program [46]. Aligned sequences were viewed using the Bioedit program [47] and were then used with the ProtDist component of the PHYLIP [48] to construct a distance matrix that was the basis for tree construction using the neighbour-joining method [49]. All trees were visualised using Treeview [50].
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
###xml 189 200 189 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 252 268 252 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 189 199 <span type="species:ncbi:1781">M. marinum</span>
###xml 252 267 <span type="species:ncbi:1773">M. tuberculosis</span>
ESV performed the cloning, expression, and characterisation of the enzyme, and assisted in writing the manuscript. CLR assisted in the cloning and expression experiments. MHK performed the M. marinum experiments. BJB conceived the study, performed the M. tuberculosis experiments, and wrote the manuscript.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
This work was funded in part by a Defence R&D Canada Technology Innovation Fund award. The authors would like to acknowledge the assistance of the University of British Columbia Science Co-op Program.
###end p 52
###begin p 53
###xml 88 112 88 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis </italic>
###xml 134 154 134 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium avium </italic>
###xml 196 218 196 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium marinum </italic>
###xml 278 301 278 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium ulcerans </italic>
###xml 88 111 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
###xml 134 153 <span type="species:ncbi:1764">Mycobacterium avium</span>
###xml 196 217 <span type="species:ncbi:1781">Mycobacterium marinum</span>
###xml 278 300 <span type="species:ncbi:1809">Mycobacterium ulcerans</span>
Preliminary genome data was made available from The Institute for Genomic Research  for Mycobacterium smegmatis (funded by NIAID) and Mycobacterium avium (funded by NIAID), The Sanger Centre  for Mycobacterium marinum (funded by Beowulf Genomics), and The Institut Pasteur  for Mycobacterium ulcerans (funded by the Association Raoul Follereau and WHO).
###end p 53
###begin article-title 54
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
###end article-title 54
###begin article-title 55
###xml 21 43 21 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 21 42 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Selective killing of Klebsiella pneumoniae by 5- trifluoromethylthioribose. Chemotherapeutic exploitation of the enzyme 5-methylthioribose kinase
###end article-title 55
###begin article-title 56
Polyamines as targets for therapeutic intervention
###end article-title 56
###begin article-title 57
Methionine recycling pathways and antimalarial drug design
###end article-title 57
###begin article-title 58
###xml 119 140 119 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae</italic>
###xml 119 140 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Affinity purification of 5-methylthioribose kinase and 5- methylthioadenosine/S-adenosylhomocysteine nucleosidase from Klebsiella pneumoniae
###end article-title 58
###begin article-title 59
###xml 77 98 77 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae</italic>
###xml 77 98 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Intermediates in the conversion of 5'-S-methylthioadenosine to methionine in Klebsiella pneumoniae
###end article-title 59
###begin article-title 60
###xml 78 99 78 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae</italic>
###xml 78 99 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Tyrosine aminotransferase catalyzes the final step of methionine recycling in Klebsiella pneumoniae
###end article-title 60
###begin article-title 61
###xml 144 165 144 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae</italic>
###xml 144 165 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Purification and characterization of an enzyme involved in oxidative carbon-carbon bond cleavage reactions in the methionine salvage pathway of Klebsiella pneumoniae
###end article-title 61
###begin article-title 62
Methionine synthesis from 5'-S-Methylthioadenosine. Resolution of enzyme activities and identification of 1-phospho-5-S methylthioribulose
###end article-title 62
###begin article-title 63
A bacterial enzyme that catalyzes formation of carbon monoxide
###end article-title 63
###begin article-title 64
###xml 34 56 34 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 34 55 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 60 63 <span type="species:ncbi:10116">rat</span>
The methionine salvage pathway in Klebsiella pneumoniae and rat liver. Identification and characterization of two novel dioxygenases
###end article-title 64
###begin article-title 65
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus </italic>
A functional link between RuBisCO-like protein of Bacillus and photosynthetic RuBisCO
###end article-title 65
###begin article-title 66
Prediction of gene function in methylthioadenosine recycling from regulatory signals
###end article-title 66
###begin article-title 67
###xml 34 51 34 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 34 51 <span type="species:ncbi:1423">Bacillus subtilis</span>
The methionine salvage pathway in Bacillus subtilis
###end article-title 67
###begin article-title 68
Identification of 2-keto-4-methylthiobutyrate as an intermediate compound in methionine synthesis from 5'-methylthioadenosine
###end article-title 68
###begin article-title 69
###xml 49 66 49 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 68 83 68 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus cereus</italic>
###xml 89 107 89 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis</italic>
###xml 49 66 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 68 83 <span type="species:ncbi:1396">Bacillus cereus</span>
###xml 89 107 <span type="species:ncbi:1392">Bacillus anthracis</span>
Methionine regeneration and aminotransferases in Bacillus subtilis, Bacillus cereus, and Bacillus anthracis
###end article-title 69
###begin article-title 70
Methionine regeneration and aspartate aminotransferase in parasitic protozoa
###end article-title 70
###begin article-title 71
###xml 147 152 <span type="species:ncbi:9606">human</span>
Characterization of a defect in the pathway for converting 5'-deoxy-5'- methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma
###end article-title 71
###begin article-title 72
###xml 93 110 93 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 93 110 <span type="species:ncbi:1423">Bacillus subtilis</span>
Cloning and characterization of the metE gene encoding S- adenosylmethionine synthetase from Bacillus subtilis
###end article-title 72
###begin article-title 73
Bacterial variations on the methionine salvage pathway
###end article-title 73
###begin article-title 74
###xml 56 80 56 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis </italic>
###xml 84 99 84 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 56 79 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
###xml 84 99 <span type="species:ncbi:1773">M. tuberculosis</span>
Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis
###end article-title 74
###begin article-title 75
Structure, evolution and action of vitamin B6-dependent enzymes
###end article-title 75
###begin article-title 76
###xml 27 54 27 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
###end article-title 76
###begin article-title 77
###xml 14 31 14 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 14 30 <span type="species:ncbi:562">Escherichia coli</span>
Structures of Escherichia coli branched-chain amino acid aminotransferase and its complexes with 4-methylvalerate and 2- methylleucine: induced fit and substrate recognition of the enzyme
###end article-title 77
###begin article-title 78
A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors
###end article-title 78
###begin article-title 79
DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase
###end article-title 79
###begin article-title 80
L-canaline: a potent antimetabolite and anti-cancer agent from leguminous plants
###end article-title 80
###begin article-title 81
Structure-activity studies of L-canaline-mediated inhibition of porcine alanine aminotransferase
###end article-title 81
###begin article-title 82
###xml 19 41 19 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium marinum </italic>
###xml 19 40 <span type="species:ncbi:1781">Mycobacterium marinum</span>
Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection
###end article-title 82
###begin article-title 83
Antimalarial activities of aminooxy compounds
###end article-title 83
###begin article-title 84
###xml 22 27 <span type="species:ncbi:9606">human</span>
Crystal structures of human mitochondrial branched chain aminotransferase reaction intermediates: ketimine and pyridoxamine phosphate forms
###end article-title 84
###begin article-title 85
Reactivity of the phosphopyridoxal groups of cystathionase
###end article-title 85
###begin article-title 86
###xml 73 94 73 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crithidia fasciculata</italic>
###xml 73 94 <span type="species:ncbi:5656">Crithidia fasciculata</span>
Methionine formation from alpha-ketomethiobutyrate in the trypanosomatid Crithidia fasciculata
###end article-title 86
###begin article-title 87
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth
###end article-title 87
###begin article-title 88
Bacteriological study of cabroxymethoxylamine hemichloride
###end article-title 88
###begin article-title 89
The antimicrobial properties of some alpha-amino-oxy-acids, alpha-amino-oxy-hydrazides, alkoxyamines, alkoxydiguanides and their derivatives
###end article-title 89
###begin article-title 90
Amino-oxy-derivatives. Part I. Some alpha-amino-oxy-acids and alpha-amino-oxy-hydrazides
###end article-title 90
###begin article-title 91
alpha-Aminooxy-acid derivatives with potent antituberculotic effect
###end article-title 91
###begin article-title 92
Amino-oxy-derivatives. Part II. Some derivatives of N-hydroxydiguanide
###end article-title 92
###begin article-title 93
###xml 15 42 15 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 15 41 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 61 65 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
###end article-title 93
###begin article-title 94
###xml 95 115 95 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium bovis </italic>
###xml 95 114 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Ornithine decarboxylase, S-adenosyl-L-methionine decarboxylase and arginine decarboxylase from Mycobacterium bovis (BCG)
###end article-title 94
###begin article-title 95
Bacterial variations on the methionine salvage pathway
###end article-title 95
###begin article-title 96
###xml 60 77 60 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 60 77 <span type="species:ncbi:1423">Bacillus subtilis</span>
The complete genome sequence of the gram-positive bacterium Bacillus subtilis
###end article-title 96
###begin article-title 97
Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands
###end article-title 97
###begin article-title 98
GenBank
###end article-title 98
###begin article-title 99
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
###end article-title 99
###begin article-title 100
Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT
###end article-title 100
###begin article-title 101
PHYLIP - phylogeny inference package (version 3.2)
###end article-title 101
###begin article-title 102
The neighbor-joining method: a new method for reconstructing phylogenetic trees
###end article-title 102
###begin article-title 103
TreeView: an application to display phylogenetic trees on personal computers
###end article-title 103
###begin article-title 104
###xml 32 51 32 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium bovis</italic>
###xml 32 51 <span type="species:ncbi:1765">Mycobacterium bovis</span>
The complete genome sequence of Mycobacterium bovis
###end article-title 104
###begin article-title 105
Massive gene decay in the leprosy bacillus
###end article-title 105
###begin article-title 106
###xml 51 75 51 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces coelicolor </italic>
###xml 38 50 <span type="species:ncbi:100235">actinomycete</span>
###xml 51 74 <span type="species:ncbi:1902">Streptomyces coelicolor</span>
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
###end article-title 106
###begin article-title 107
###xml 15 18 <span type="species:ncbi:10116">rat</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Cloning of the rat and human mitochondrial branched chain aminotransferases (BCATm)
###end article-title 107
###begin article-title 108
###xml 46 63 46 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 46 62 <span type="species:ncbi:562">Escherichia coli</span>
Branched-chain amino acid aminotransferase of Escherichia coli : nucleotide sequence of the ilvE gene and the deduced amino acid sequence
###end article-title 108
###begin title 109
Figures and Tables
###end title 109
###begin p 110
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The formation of Met from KMTB. </bold>
###xml 123 137 123 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 146 158 146 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 235 251 235 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 123 136 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 146 157 <span type="species:ncbi:1423">B. subtilis</span>
###xml 235 250 <span type="species:ncbi:1773">M. tuberculosis</span>
The formation of Met from KMTB. The pathway of polyamine synthesis and subsequent Met regeneration from MTA, as known from K. pneumoniae [11] and B. subtilis [12], is shown. Solid arrows represent steps that have been characterised in M. tuberculosis (present study and [21]). The conversion of KMTB to Met is shown at the top in bold. KIC = ketoisocaproate, KIV = ketoisovalerate, and KMV = ketomethylvalerate.
###end p 110
###begin p 111
###xml 16 32 16 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relationship of <italic>M. tuberculosis </italic>BCAT to other family III aminotransferases. </bold>
###xml 257 273 257 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 16 31 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 257 272 <span type="species:ncbi:1773">M. tuberculosis</span>
Relationship of M. tuberculosis BCAT to other family III aminotransferases. In (A) selected subfamily IIIa and IIIb aminotransferases were aligned and a tree constructed by the neighbor-joining method [49] in order to define the subfamily membership of the M. tuberculosis BCAT (in blue). In (B) subfamily IIIa BCATs were aligned and a cladogram constructed by the neighbor-joining method. The numbers represent the bootstrap values (in percentage) for each branch point.
###end p 111
###begin p 112
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of selected family III aminotransferases. </bold>
###xml 126 142 126 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 162 171 162 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. bovis </italic>
###xml 191 202 191 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 217 229 217 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. ulcerans </italic>
###xml 244 254 244 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. leprae </italic>
###xml 274 283 274 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. avium </italic>
###xml 299 312 299 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 328 352 328 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces coelicolor </italic>
###xml 372 390 372 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 443 460 443 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 485 498 485 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. anthracis </italic>
###xml 519 531 519 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 126 141 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 162 170 <span type="species:ncbi:1765">M. bovis</span>
###xml 191 201 <span type="species:ncbi:1781">M. marinum</span>
###xml 217 228 <span type="species:ncbi:1809">M. ulcerans</span>
###xml 244 253 <span type="species:ncbi:1769">M. leprae</span>
###xml 274 282 <span type="species:ncbi:1764">M. avium</span>
###xml 299 311 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 328 351 <span type="species:ncbi:1902">Streptomyces coelicolor</span>
###xml 372 389 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 443 459 <span type="species:ncbi:562">Escherichia coli</span>
###xml 485 497 <span type="species:ncbi:1392">B. anthracis</span>
###xml 519 530 <span type="species:ncbi:1423">B. subtilis</span>
Alignment of selected family III aminotransferases. The following sequences were aligned with the Clustal algorithm: Mt-BCAT, M. tuberculosis BCAT [23]; Mb-BCAT, M. bovis BCAT [51]; Mm-BCAT, M. marinum BCAT; Mu-BCAT, M. ulcerans BCAT; Ml-BCAT, M. leprae BCAT [52]; Ma-BCAT, M. avium BCAT; Ms- BCAT, M. smegmatis BCAT; Sc- BCAT, Streptomyces coelicolor BCAT [53]; Bs-BCAT, Bacillus subtilis BCAT YbgE [43]; Hs-BCAT1, human BCAT1 [54]; Ec-BCAT, Escherichia coli BCAT IlvE [55]; Ba-BCAT, B. anthracis BCAT2 [16]; Bs-DAAT, B. subtilis DAAT YheM [43]). Residues conserved by 80% of the sequences are shown in blue. The boxed residues represent the pyridoxal-5-phosphate binding site.
###end p 112
###begin p 113
###xml 28 44 28 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Purification of recombinant <italic>M. tuberculosis </italic>BCAT. </bold>
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 307 309 307 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 28 43 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 50 62 <span type="species:ncbi:511693">E. coli BL21</span>
Purification of recombinant M. tuberculosis BCAT. E. coli BL21(DE3) CodonPlus-RIL cells were induced with IPTG and prepared as described in the Materials and Methods section. The cell lysate was separated by centrifugation into pellet (P) and supernatant (S) fractions. The supernatant was loaded onto an Ni2+-charged metal ion affinity column and flow through (F), 80 mM imidazole (W), and 800 mM imidazole (E) fractions were collected. Aliquots of each fraction were analysed on a 10% polyacrylamide gel under reducing conditions. Lane (M) contains molecular mass markers (units in kDa).
###end p 113
###begin p 114
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The amino donor range for Met formation. </bold>
The amino donor range for Met formation. The enzyme was mixed with 1.0 mM KMTB, 2.0 mM of an individual amino acid, and PLP for 30 min at 37degreesC before HPLC analysis of Met production.
###end p 114
###begin p 115
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of branched-chain aminotransferase by aminooxy compounds. </bold>
Inhibition of branched-chain aminotransferase by aminooxy compounds. Leucine, KMTB, PLP and 1 mM (black bars) or 0.1 mM (white bars) of inhibitor were incubated with Mt-BCAT as described in the Methods section. Percent activity is shown relative to a positive control which contained no inhibitor.
###end p 115
###begin p 116
###xml 28 44 28 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 28 43 <span type="species:ncbi:1773">M. tuberculosis</span>
Kinetic characterization of M. tuberculosis branched-chain aminotransferase. The enzyme was incubated with varying concentrations of substrate and 10 mM cosubstrate, as described in the Methods section.
###end p 116
###begin p 117
Ki determination for selected aminooxy inhibitors. The enzyme was incubated with variable amounts of leucine and inhibitor and fixed amounts of KMTB, as described in the Methods section. Kic and Kiu refer to the competitive and uncompetitive components of mixed-type inhibition [25].
###end p 117
###begin p 118
*200 muM was the highest concentration of inhibitor tested in these experiments. The calculated Kiu value is shown in parentheses.
###end p 118
###begin p 119
###xml 30 45 30 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M tuberculosis </italic>
###xml 49 60 49 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 131 147 130 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 150 161 149 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum </italic>
###xml 189 191 188 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 346 361 338 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 388 398 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. marinum</italic>
###xml 454 460 440 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">650 nm</sub>
###xml 49 59 <span type="species:ncbi:1781">M. marinum</span>
###xml 131 146 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 150 160 <span type="species:ncbi:1781">M. marinum</span>
###xml 346 361 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 388 398 <span type="species:ncbi:1781">M. marinum</span>
In vitro growth inhibition of M tuberculosis and M. marinum by aminooxy compounds. One hundred muL of a mid-logarithmic culture of M. tuberculosis or M. marinum at a concentration of 2 x 105 cfu/ml was added to 100 muL of serial doubling dilutions of inhibitor in a 96-well microtitre plate. The drug plates were grown for 14 days at 37degreesC (M. tuberculosis) or 8 days at 30degreesC (M. marinum) with no agitation before checking for cell growth at A650 nm. The minimum inhibitory concentration (MIC) and inhibitory concentration 50% (IC50) were calculated as described in the Methods section.
###end p 119

